PURE PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of PURE PHARMA is 1.9% (moderate). The 2025 annual accounts show equity of €383,549 and a net result of -€256,645. Equity is growing by about 9.5% per year across the filed financial years. Its solvency ranks better than 28% of 1,021 sector peers (NACE 41, financial year 2025). The company has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
DE COENE INTERIOR DECORATION
Shared corporate director
→
VERTEAU
Shared corporate director
→